Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 164 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
2. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
3. Cita con resumen
Young K. FDA advisers back approval of first drug for female sexual dysfunction. Journal Watch 2015:1. [Ref.ID 99241]
4. Cita con resumen
Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang -CH, Ho H-C, Chen MJ, Lin JY, Hui C-Y, Ho J-C, Wu W-M, Chen T-J, Wu T, Wu Y-R, Hsih M-S, Tu P-H, Chang C-N, Hsu C-N, Wu T-L, Choon S-E, Hsu C-K, Chen D-Y, Liu C-S, Lin C-Y, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang T-H, Chuang S-S, Tsai S-F, Chang C-J, Chang YS, Hung S-I, for the Taiwan Severe Cutaneous Adverse Reaction Consortium and the Japan Pharmacogenomics Data Science Consortium. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014;312:525-34. [Ref.ID 97851]
5. Cita con resumen
Anónimo. Vortioxetine (Brintellix) for depression. Med Lett Drugs Ther 2013;55:93. [Ref.ID 96686]
6.Tiene citas relacionadas Cita con resumen
Furie B. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?. N Engl J Med 2013;369:2345-6. [Ref.ID 96668]
7.Tiene citas relacionadas Cita con resumen
Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, Kesteven P, Christersson C, Wahlström B, Stafberg C, Zhang JE, Williamson PR, Daly AK, Avery P, Kamali F, Wadelius M, for the EU-PACT Group. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013;369:2294-303. [Ref.ID 96665]
8. Cita con resumen
Wright DFB, Al-Sallami HS, Duffull SB. Is the dose of dabigatran really more predictable than warfarin?. Br J Clin Pharmacol 2013;76:997-8. [Ref.ID 96634]
9. Cita con resumen
Anónimo. Dabrafenib (Tafinlar) and trametinib (Mekinist) for metastatic melanoma. Med Lett Drugs Ther 2013;55:62-3. [Ref.ID 95948]
10. Cita con resumen
Anónimo. Mifepristone (Korlym) for Cushing's syndrome. Med Lett Drugs Ther 2012;54:46-7. [Ref.ID 93205]
11.Tiene citas relacionadas Cita con resumen
Niessen SE. Pharmacogenomics and clopidogrel: irrational exuberance?. JAMA 2011;306:2727-8. [Ref.ID 91942]
12.Tiene citas relacionadas Cita con resumen
Holmes MV, Perel P, Shah T, Hingorani AD, Casas JP. CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA 2011;306:2704-14. [Ref.ID 91940]
13.Enlace a cita original
Hang XF, Xu WS, Wang JX, Wang L, Xin HG, Zhang RQ, Ni W. Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2011;67:613-23. [Ref.ID 90891]
14.Enlace a cita original
Holstein A, Hahn M, Patzer O, Seeringer A, Kovacs P, Stingl J. Impact of clinical factors and CYP2C9 variants for the risk of severe sylfonylurea-induced hypoglycemia. Eur J Clin Pharmacol 2011;67:471-6. [Ref.ID 90587]
15. Cita con resumen
Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S. Fibrate/statin initiation in warfarin users and gastrointestinal bleeding risk. The American Journal of Medicine 2010;123:151-7. [Ref.ID 88202]
16.Tiene citas relacionadas Cita con resumen
The International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 2009;360:753-64. [Ref.ID 85287]
17.Tiene citas relacionadas Cita con resumen
Stein CM, Roden DM, Schwarz UI. Genetics of warfarin response. The authors reply. N Engl J Med 2008;358:2743-4. [Ref.ID 83290]
18.Tiene citas relacionadas Cita con resumen
Neville KA, Wicklund BM, Kearns GL. Genetics of warfarin response. N Engl J Med 2008;358:2742. [Ref.ID 83287]
19. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
20.Tiene citas relacionadas Cita con resumen
Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008;358:999-1008. [Ref.ID 82422]
Seleccionar todas
 
 1 a 20 de 164 siguiente >>